Literature DB >> 21764355

Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.

Claudia Cocco1, Irma Airoldi.   

Abstract

B-acute lymphoblastic leukemia (ALL) is the most common hematologic tumor of pediatric age. Although patient survival has been improved, some cases still relapse and need alternative therapies. In this context, the role of microRNA in cancer is actually matter of investigation due to their regulatory function implicated in human tumorigenesis since the main target mRNA transcripts are involved in proliferation, apoptosis and differentiation. On the other hand, cytokines are actually used as adjuvants in B-ALL therapy, and recent studies reported that they may also function by acting directly against leukemic cells. Here we review the current knowledge about the role of miRNA and cytokines in B-ALL, highlighting the link between cytokine activity and miRNA expression. The translational relevance of these issues will be also discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764355     DOI: 10.1016/j.cytogfr.2011.05.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  5 in total

1.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

2.  Bone Marrow Cells in Acute Lymphoblastic Leukemia Create a Proinflammatory Microenvironment Influencing Normal Hematopoietic Differentiation Fates.

Authors:  Armando Vilchis-Ordoñez; Adriana Contreras-Quiroz; Eduardo Vadillo; Elisa Dorantes-Acosta; Alfonso Reyes-López; Henry Martin Quintela-Nuñez del Prado; Jorge Venegas-Vázquez; Hector Mayani; Vianney Ortiz-Navarrete; Briceida López-Martínez; Rosana Pelayo
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 3.  The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy.

Authors:  Carle Grobbelaar; Anthony M Ford
Journal:  J Oncol       Date:  2019-10-13       Impact factor: 4.375

4.  MicroRNAs Involved in Anti-Tumour Immunity.

Authors:  Hong W H Yu; Daniel M Y Sze; William C S Cho
Journal:  Int J Mol Sci       Date:  2013-03-11       Impact factor: 5.923

Review 5.  Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Authors:  Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti; Alessandra Cappellini; Francesca Buontempo; Daniela Bressanin; Milena Fini; James A McCubrey
Journal:  Oncotarget       Date:  2012-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.